2016
DOI: 10.1007/978-1-4939-3618-2_20
|View full text |Cite
|
Sign up to set email alerts
|

Generation of Mouse Monoclonal Antibodies Specific to Chikungunya Virus Using ClonaCell-HY Hybridoma Cloning Kit

Abstract: Monoclonal antibodies offer high specificity and this makes it an important tool for molecular biology, biochemistry and medicine. Typically, monoclonal antibodies are generated by fusing mouse spleen cells that have been immunized with the desired antigen with myeloma cells to create immortalized hybridomas. Here, we describe the generation of monoclonal antibodies that are specific to Chikungunya virus using ClonaCell-HY system.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…A fusion of human B cells with different fusion partners limits the use of these mAbs for therapeutic applications. Several hetero-myelomas fusion has been successfully employed for the generation of mAbs of human origin for different diseases like HIV [28,55], Chikungunya [56,57], Dengue [58] etc. However, such hybridomas are Fig.…”
Section: Humanmentioning
confidence: 99%
See 2 more Smart Citations
“…A fusion of human B cells with different fusion partners limits the use of these mAbs for therapeutic applications. Several hetero-myelomas fusion has been successfully employed for the generation of mAbs of human origin for different diseases like HIV [28,55], Chikungunya [56,57], Dengue [58] etc. However, such hybridomas are Fig.…”
Section: Humanmentioning
confidence: 99%
“…In this strategy, they immunized the mice with transfected cells overexpressing PDPN and screened the fused hybridoma cells using flow cytometry. These cell-based immunization methods are useful in the isolation of mAbs against various membrane proteins which is still difficult to achieve otherwise [56,57].…”
Section: Challenges and Advancement In Hybridoma Technology Over The Yearsmentioning
confidence: 99%
See 1 more Smart Citation